Recall Radar
All recallsMedicine & devices

Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th Floor, New York, NY 10016, USA, NDC 72972-0…

Lack of Assurance of Sterility

Class II Medicine & devices FDA May 6, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
SCOPE HEALTH — New York, NY
Severity
Class II — moderate
Reported
May 6, 2026
Recall number
D-0499-2026
Status
Ongoing
Source
FDA

Where it went

Nationwide within the United States

Other medicine & devices recalls

See every current recall on the live dashboard →